Litigation Funding in Israel (2026): Rules, Risks and How Businesses Can Use Third‑party Finance

Litigation funding israel is fast becoming a board‑level question as crowded dockets, lengthening timetables and rising legal spend push businesses to look beyond their own balance sheets to pursue meritorious claims. Third‑party finance lets a company convert a legal claim into an off‑balance‑sheet asset, preserving working capital while a funder absorbs the cost and much of the downside risk. This 2026 guide explains how litigation funding works in Israel, which claims attract capital, how the Israeli courts treat disclosure and security for costs, and how to negotiate a funding agreement that protects your interests. It is written for commercial decision‑makers but carries enough legal detail to be useful to in‑house and external counsel preparing a funded matter.

Quick summary: is litigation funding in Israel right for your business?

Before engaging a funder, run a short commercial test. Funding tends to make sense when the claim is strong on the merits, the sums at stake are large relative to the cost of pursuing them, and the defendant is good for the money if you win. It is less attractive where damages are modest, enforcement prospects are weak, or the dispute is primarily reputational rather than monetary.

• Claim size. Funders generally need damages that are large relative to the cost of pursuing them, so that after their share and legal fees a meaningful recovery remains for the claimant.
• Probability of success. The legal and factual strength of the claim drives both whether a funder will invest and the price of that capital.
• Cashflow constraints. Funding is most compelling where paying lawyers from cash would strain the business or divert capital from operations.
• Enforcement prospects. A judgment you cannot enforce is worthless to a funder. Solvent, locatable defendants with reachable assets are essential.

When not to use funding: if you can comfortably self‑finance a high‑probability, low‑risk claim, the cost of a funder’s success share will usually outweigh the benefit of transferring risk you did not need to transfer.

What is third‑party litigation finance in Israel and how does it work?

Third‑party litigation finance in Israel is an arrangement under which an unconnected funder pays some or all of the costs of pursuing a claim, lawyers’ fees, experts, court fees and disbursements, in return for an agreed share of any recovery. Crucially, the funding is typically non‑recourse: if the claim fails, the funder loses its investment and the claimant generally owes nothing beyond what the agreement provides. That asymmetry is the core commercial attraction of dispute financing israel, and it is what distinguishes funding from a conventional loan.

Typical commercial models: portfolio versus single‑case

Single‑case funding is the simplest structure: a funder backs one identified claim and takes its return from that claim’s proceeds. Portfolio funding spreads capital across a bundle of cases, often several claims run by the same company or the same law firm, so that the funder’s risk is diversified. Portfolio arrangements usually carry a lower blended cost of capital because losses on one matter are offset by wins on others, and they suit businesses with a recurring pipeline of disputes.

Fee structures: success fee, hybrid and non‑recourse

Funders price their capital in several ways. A common approach is a success fee expressed as a multiple of the amount deployed or as a percentage of the net recovery. Hybrid structures combine a percentage with a capped multiple, with one or other applying depending on the timing and size of resolution. Non‑recourse legal funding israel means the claimant’s exposure is generally limited to the agreed share of proceeds, there is typically no personal or corporate repayment obligation if the case is lost, provided the agreement is drafted cleanly to that effect.

The typical funding lifecycle

A funded matter moves through four broad stages. First, due diligence: the funder and its external counsel assess the merits, quantum, defendant solvency and budget. Second, funding: terms are agreed and documented in a funding agreement, with capital committed against a litigation budget. Third, case management: the funder monitors progress against milestones while the claimant and its lawyers retain conduct of the litigation. Fourth, exit: on settlement or judgment, proceeds flow through an agreed priority waterfall that repays deployed capital, pays the funder’s return, and distributes the balance to the claimant.

Which Israeli claims are fundable?

Not every dispute attracts capital. Funders look for claims with clear liability theories, quantifiable damages and realistic enforcement. Commercial claims funding israel is the heartland of the market, but the picture varies by claim type.

Commercial claims: contract, IP and shareholder disputes

High‑value contract claims, intellectual property disputes and shareholder or corporate‑governance litigation are among the most fundable categories. These cases typically involve sophisticated commercial parties, documentary evidence and damages that can be modelled with reasonable confidence. IP matters in particular, patent, trade secret and licensing disputes, attract specialist funders because the quantum can be large and the technical merits can be assessed in advance.

Class and collective actions: practical considerations

Class actions in Israel are governed by the Class Actions Law, 5766‑2006, and the courts exercise close supervision over certification, conduct and settlement. Collective proceedings can be fundable, but they carry particular sensitivities. Certification risk, the length of such proceedings and the court’s supervisory role over any settlement all affect the funder’s analysis. Representative claimants and their counsel should expect close scrutiny of the funding arrangement and should anticipate that the court may take an interest in how any recovery is distributed and how the funder’s involvement affects the represented group’s interests.

Non‑fundable or difficult claims

Funders avoid claims that are weak on the merits, carry only modest damages, or target defendants in enforcement‑poor jurisdictions. Claims driven by principle rather than money, matters where the limitation position is doubtful, and disputes with uncertain or intangible loss rarely clear a funder’s investment committee. A frivolous or speculative claim will not attract capital, and attempting to fund one wastes the time of all concerned.

Legal landscape for litigation funding israel: key rules, court practice and disclosure

Israel does not have a comprehensive statutory code governing third‑party funding. There is no general statutory prohibition on funding commercial litigation, and in practice the field is shaped by the procedural rules applied by the courts, by professional‑conduct standards, and by developing case law rather than by a single dedicated statute (Ministry of Justice; Israel Bar Association). For businesses, that means the terrain of litigation funding israel is governed by how the courts handle disclosure, costs and conduct, and by the ethical rules that bind the lawyers running the case.

Disclosure to the court and opponents

Whether the existence of a funder must be disclosed is context‑dependent. Israeli procedure does not impose a blanket, automatic obligation to reveal every funding arrangement in ordinary commercial litigation, but disclosure may become relevant in specific situations, for example, where the funding bears on an application for security for costs, or where a potential conflict of interest or control issue is raised (Israel Courts). In the class‑action context, courts have shown a particular interest in third‑party funding of representative proceedings. The prudent approach is to assume that the arrangement, or at least its material features, may come to light, and to structure the deal so that disclosure would not embarrass the claimant or compromise its position.

Security for costs orders and their effect on funders

Israeli courts have the power to order a claimant to provide security for the defendant’s costs, and they apply established criteria when deciding whether to do so, weighing matters such as the claimant’s financial position and the prospects of the claim (Israel Courts). The presence of a funder is relevant here in two directions: a defendant may argue that a funded claimant should post security because the real economic interest lies with a third party, while a well‑capitalised funder can often support a security requirement that an impecunious claimant could not. Funders routinely price and plan for the possibility of a security order, and the funding agreement should make clear who bears the cost of providing it.

Champerty and maintenance: historical doctrine, modern approach

The old common‑law concerns about maintenance (supporting another’s litigation) and champerty (doing so for a share of the proceeds) have shaped judicial attitudes to funding in many jurisdictions. Israeli law does not apply those doctrines as strict prohibitions, and the general trend is a permissive one: commercial funding that improves access to justice is tolerated, provided the funder does not improperly control the litigation, stir up unmeritorious claims, or distort the administration of justice. The practical lesson for a funding agreement is to keep conduct of the case in the hands of the claimant and its lawyers, and to confine the funder’s role to legitimate commercial oversight.

Funding agreements: essential terms and negotiation checklist

The funding agreement israel governs the economic and control relationship between claimant and funder. It is the single most important document in any funded matter, and it rewards careful negotiation. The sections below set out the core terms and offer illustrative clause language. The sample wording is a non‑binding illustration only and is not legal advice; every agreement must be drafted to the specific matter.

Economic terms: success fee, cap, priority waterfall and recovery splits

The economics turn on how proceeds are divided. Agreements usually define a priority waterfall: deployed capital is repaid first, the funder’s return is paid next, and the claimant takes the balance. Negotiate a cap on the funder’s return so that a very large or very early recovery does not leave the claimant with a disproportionately small share, and insist that the claimant retains a meaningful minimum percentage of net proceeds regardless of outcome.

Illustrative clause (non‑binding): “Recovery Proceeds shall be applied in the following order of priority: (i) reimbursement of the Funder’s Deployed Capital; (ii) the Funder’s Return, being the greater of [X]% of net Recovery Proceeds and [Y] times Deployed Capital, subject to the Cap; (iii) the balance to the Claimant.”

Control rights and conduct of the litigation

Control is where funder and claimant interests can collide. The claimant must retain conduct of the litigation and the ultimate right to instruct its lawyers; the funder legitimately wants information and a say on settlement. A balanced agreement gives the funder consultation and information rights, perhaps a structured settlement‑approval mechanism with an independent‑counsel deadlock resolver, but never direct control over tactical decisions. Over‑broad control rights invite the very concerns the parties should be avoiding.

• Information rights. Regular updates, access to pleadings and advice on strategy, subject to privilege protections.
• Settlement rights. A duty to consult and a reasonable‑approval standard, with an independent mechanism to resolve disagreement rather than a unilateral funder veto.
• Conduct. Express confirmation that the claimant and its lawyers retain conduct and that the funder will not interfere with the lawyer’s professional duties.

Reporting, milestones and funding cessation

Funders commit capital against a budget and expect to track progress. The agreement should set reporting intervals, define budget milestones, and specify the circumstances in which the funder may stop funding, typically a material adverse change in the merits, a budget overrun, or a breach by the claimant. Negotiate a wind‑down provision so that if funding ceases, the claimant is not left exposed mid‑trial, and clarify the funder’s entitlement (if any) to amounts already deployed.

Confidentiality, privilege and data handling

Sharing case information with a funder raises privilege questions. The agreement should include robust confidentiality undertakings, record the parties’ common interest in the outcome, and limit the information shared to what the funder genuinely needs. Handle documents through counsel where possible, mark materials appropriately, and avoid waiving privilege by over‑sharing. Data‑handling provisions should address storage, access and return or destruction of materials at the end of the engagement.

Risks and how to mitigate them

Funding transfers risk but does not eliminate it. Each side of the dispute, and the cross‑border dimension, carries distinct hazards that sensible structuring can reduce.

Risks to the claimant

The principal claimant‑side risks are loss of control, the cost of the funder’s return, and exposure to adverse costs. A poorly drafted agreement can hand the funder too much influence over settlement; the mitigation is clear control language. The funder’s share reduces net recovery; the mitigation is a negotiated cap and minimum claimant share. And if the claimant loses, it may face a costs order, which is why the funding and any cost‑protection arrangements must address who meets an adverse award.

Risks to the defendant

From the defendant’s perspective, funding can prolong litigation that a cash‑constrained claimant might otherwise have abandoned, and it introduces a third party with an economic interest in the outcome. Defendants increasingly probe for the existence of funding and may deploy security‑for‑costs applications to neutralise the advantage. Where a funded claimant is thinly capitalised, a security order can be a powerful tool.

Tax, enforcement and cross‑border risk

The tax treatment of funding receipts and the funder’s return should be assessed with advisers before signing, as the characterisation of proceeds can affect the net economics. Enforcement risk is existential: a judgment against an unreachable defendant yields nothing. In cross‑border matters and international arbitration, disclosure of funding is an area of active development, and international guidance on third‑party funding and disclosure in arbitration should inform how the arrangement is structured and revealed (UNCITRAL). Where enforcement will take place abroad, confirm early that a funded award can be recognised and enforced in the relevant jurisdiction.

How to run due diligence on a funder

Choosing a funder is a commercial counterparty decision. The claimant is entering a multi‑year relationship with a party that will have deep knowledge of its case, so diligence should be reciprocal, the funder examines the claim, and the claimant examines the funder.

Commercial, legal and regulatory checks

• Capital and commitment. Confirm the funder has committed, drawable capital for the full life of the case, not merely an intention to raise it.
• Track record. Ask about comparable funded matters, how the funder behaved at settlement, and whether it has ever withdrawn funding.
• Governance. Understand who sits on the investment committee and how decisions to continue or cease funding are made.
• Conflicts. Check for any connection between the funder, the opponent, or counsel that could create a conflict.

Red flags and contractual protections

Warning signs include reluctance to confirm committed capital, demands for excessive control, vague or unilateral termination rights, and unwillingness to cap returns. Protect against these with precise drawdown obligations, clear cessation triggers, a return cap, and dispute‑resolution machinery within the funding agreement itself. A funder that resists reasonable protections is telling you something about how it will behave if the case turns difficult.

Alternatives and comparison: funding options for Israeli disputes

Third‑party funding is one of several ways to finance a claim. The right choice depends on cost tolerance, appetite for risk, the importance of retaining control, and the nature of the dispute. The table below compares the main options as they apply in Israel.

Practical steps to close a litigation funding deal in Israel

Moving from interest to committed capital follows a recognisable path, and understanding it helps businesses manage timelines and stakeholders.

Deal steps

1. Letter of intent. The funder sets out indicative terms, exclusivity and the scope of diligence.
2. Due diligence. The funder’s external counsel reviews merits, quantum, defendant solvency and budget.
3. Funding agreement. The parties negotiate and execute the definitive terms, including the waterfall, control rights and cessation triggers.
4. Drawdown. Capital is released against the agreed budget and milestones as the case proceeds.

Typical timeline and stakeholder map

Diligence and documentation commonly take several weeks to a few months, depending on the complexity of the claim and the speed of information exchange. Key stakeholders include the general counsel or CFO sponsoring the deal, external litigation counsel, the funder’s investment team and its diligence lawyers, and, where costs protection is involved, an ATE insurer. Aligning these parties early avoids delay and keeps the litigation timetable intact.

Case studies and hypotheticals

Commercial contract claim. A mid‑sized Israeli company has a strong breach‑of‑contract claim worth a substantial sum but cannot justify diverting cash from operations to fund it. A single‑case funder commits the budget on a non‑recourse basis in exchange for a capped share of net proceeds. The matter settles before trial; after the waterfall repays deployed capital and the funder’s return, the company retains the large majority of the net recovery it would otherwise never have pursued.

Intellectual property dispute. A technology business holds a valuable trade‑secret claim against a former partner but faces a well‑resourced defendant and uncertain enforcement. A specialist IP funder backs the claim and arranges adverse‑costs protection. The defendant applies for security for costs; because the funder is well‑capitalised, the claimant meets the order without destabilising the case. The matter resolves on terms that cover the funder’s return and leave the business with a meaningful share of the proceeds.

Next steps: evaluating litigation funding israel for your dispute

Litigation funding israel gives well‑advised businesses a powerful way to pursue strong claims without committing scarce capital, but the value lies in the detail, the merits assessment, the waterfall, the control rights, and the interaction with disclosure and security for costs. General counsel and CFOs should start with the commercial test set out above, run disciplined diligence on any funder, and negotiate a funding agreement that caps the funder’s return and keeps conduct of the case firmly in the claimant’s hands. To evaluate funding for a specific Israeli dispute, speak with experienced litigation counsel who can assess the claim, model the economics and manage the funder relationship.

Explore the Litigation practice, Israel and find litigation lawyers in Israel to connect with counsel who can help you structure third‑party finance with confidence.

Sources

1. The Judicial Authority of Israel (Israel Courts)
2. The Supreme Court of Israel, judgments
3. Ministry of Justice (Israel)
4. Knesset (Israeli legislature)
5. Israel Bar Association
6. UNCITRAL (UN Commission on International Trade Law)